Article View: ca.general
Article #21315Europe and the FDA (Was: Re: Respose to Prop 186 biffs
From: charles hobbs
Date: Sat, 24 Sep 1994 17:51
Date: Sat, 24 Sep 1994 17:51
9 lines
1071 bytes
1071 bytes
In a previous article, george@nccu.edu (conklin) says: > Any drug approved in Europe should be available here. Period. > Why just Europe? What about Japan? And all of Europe? France and germany may be obvious, but what about some of the less-organized places (Greece, Spain)?
Technical Details
Message-ID:
<1994Sep24.175133.26204@lafn.org>Path:
arc1-ca.pugleaf.net!bga.com!news.sprintlink.net!howland.reston.ans.net!swrinde!sgiblab!pacbell.com!amdahl!netcomsv!lafn.org!lafn.org!ab415References:
<CwJL0M.94t@ecsvax.uncecs.edu> <35nu5s$ejd@mizar.usc.edu> <CwHAHG.BI7@ecsvax.uncecs.edu> <35qba3$3m4@mizar.usc.edu>Show Full Headers
Complete Article Headers
X-Google-Language: ENGLISH,ASCII-7-bit X-Google-Thread: 106ed4,47c5ad75440d420f X-Google-Attributes: gid106ed4,public X-Google-ArrivalTime: 1994-09-24 12:11:52 PST Newsgroups: ca.general Path: arc1-ca.pugleaf.net!bga.com!news.sprintlink.net!howland.reston.ans.net!swrinde!sgiblab!pacbell.com!amdahl!netcomsv!lafn.org!lafn.org!ab415 From: ab415@lafn.org (charles hobbs) Subject: Europe and the FDA (Was: Re: Respose to Prop 186 biffs Message-ID: <1994Sep24.175133.26204@lafn.org> Sender: news@lafn.org Nntp-Posting-Host: lafn.org Reply-To: ab415@lafn.org (charles hobbs) Organization: The Los Angeles Free-Net References: <CwJL0M.94t@ecsvax.uncecs.edu> <35nu5s$ejd@mizar.usc.edu> <CwHAHG.BI7@ecsvax.uncecs.edu> <35qba3$3m4@mizar.usc.edu> Date: Sat, 24 Sep 1994 17:51:33 GMT Lines: 9